Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.

ABSTRACT:

Background

L-carnitine mediates the utilization of fatty acids and glucose in the myocardium. The potential of L-carnitine in managing dilated cardiomyopathy (DCM) in patients has been extensively reported, with additional benefits.

Objective

This meta-analysis purposed to explore the clinical efficacy of L-carnitine therapy on DCM patients.

Methods

We searched publications up to May 2020 from several databases including PubMed, Embase, Cochrane Library, Chinese Biomedical (CBM) database, Chinese Science and Technology Periodicals database (VIP), Chinese National Knowledge Infrastructure (CNKI) database, and Wanfang database. Subsequently, publications that met the inclusion criteria were systematically evaluated by two independent reviewers.

Results

A total of

SUBMITTER: Weng Y 

PROVIDER: S-EPMC7817303 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature